The SOURT OUT IV TRIAL
NCT00552877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2678
Last updated 2009-08-13
Summary
In a randomized study the Xience V coroary artery stent may be non inferior to the Cypher Select+ coronary stents in the treatment of unselected patients with coronary artery disease.
Conditions
- Ischemic Heart Disease
- Coronary Atherosclerosis
- Percutaneous Coronary Intervention
Interventions
- DEVICE
-
Percutaneous coronary intervention (Xience V stent)
Cypher Select plus coronary stent Xience V coronary stent
Sponsors & Collaborators
-
Odense University Hospital
lead OTHER
Principal Investigators
-
Per Thayssen, MD DMSci · Odense University Hospital, Dept. of Cardiology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2009-08-31
- Completion
- 2009-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)
NCT00403338 ·Status: COMPLETED
-
Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention
NCT06692140 ·Status: RECRUITING ·Phase: NA
-
Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent
NCT03952273 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
NCT01879358 ·Status: UNKNOWN ·Phase: NA
-
Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
NCT05952206 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)
NCT01078038 ·Status: COMPLETED ·Phase: PHASE4
-
SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe
NCT00402272 ·Status: COMPLETED ·Phase: PHASE4
-
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
NCT00485030 ·Status: COMPLETED ·Phase: PHASE4
-
OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation
NCT02504307 ·Status: COMPLETED ·Phase: PHASE4
-
The 3D Stent Study
NCT06898021 ·Status: RECRUITING
-
The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.
NCT00232791 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
NCT05981911 ·Status: RECRUITING
-
Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
NCT01788150 ·Status: COMPLETED ·Phase: NA
-
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
NCT00638794 ·Status: COMPLETED
-
Comparison of Cypher Select and Taxus Express Coronary Stents
NCT00388934 ·Status: COMPLETED ·Phase: PHASE4
-
SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System
NCT00307047 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.
NCT00232856 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL)
NCT02076516 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period
NCT00882219 ·Status: COMPLETED ·Phase: PHASE3
-
Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent
NCT02870140 ·Status: COMPLETED ·Phase: NA
-
EXCEL Clinical Trial
NCT01205776 ·Status: COMPLETED ·Phase: NA
-
XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study
NCT00631228 ·Status: COMPLETED
-
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease
NCT00531011 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT02579031 ·Status: COMPLETED ·Phase: NA
-
Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients
NCT00660478 ·Status: COMPLETED ·Phase: PHASE3